PROFUSA, INC. Net Asset Value Per Share
PROFUSA, INC. (PFSA) had Net Asset Value Per Share of $9.20 per share as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:NetAssetValuePerShare · last filed 2023-11-20
- 2023-09-30: Net Asset Value Per Share $9.20.
- 2023-06-30: Net Asset Value Per Share $9.20.
- 2023-03-31: Net Asset Value Per Share $9.20.
| Period end | Net Asset Value Per Share |
|---|---|
| 2023-09-30 | $9.20 10-Q · filed 2023-11-20 |
| 2023-06-30 | $9.20 10-Q · filed 2023-08-14 |
| 2023-03-31 | $9.20 10-Q · filed 2023-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |